Left ventricular morphology and function in diabetic and nondiabetic hemodialyzed patients

Morbidity in end‐stage renal disease (ESRD) diabetic patients is worse than in patients without diabetes mellitus (DM). This study aims to compare clinical, laboratory, and echocardiographic features between the ESRD patients with and without DM. Fifty‐eight ESRD patients on dialysis were prospectively divided into two groups according to the presence of DM. Demographic, clinical, laboratory, and echocardiographic features (ejection fraction and wall motion score index) were compared between the two groups. Overall, 20 out of 58 patients (37.8%) with ESRD had DM. There were no significant differences between the patients with DM and those without DM when it comes to age (60.6 ± 10.6 vs. 59.0 ± 10.6 years, P = 0.665), ejection fraction (52.6% ± 12.8% vs. 54.2% ± 12.8%, P = 0.59), and wall motion score index (1.21 ± 0.3 vs.1.15 ± 0.3, P = 0.37). In multivariant analysis of the interventricular septum, posterior wall thickness and left atrium size correlated positively with DM. There was also no statistical difference in myocardial perfusion disturbances on real‐time contrast echocardiography between the groups with and without DM (12 (60%) patients vs. 14 patients (36.8%), P = 0.079). Among diabetics 77.8% had significant atherosclerotic changes, while in the group without DM, only 38.1%, P = 0.01. From the laboratory parameters ferritin and high‐sensitivity C‐reactive protein levels were significantly higher in the group with DM, P = 0.014 and P = 0.026, respectively. Patients with ESRD and DM have significantly bigger left atrial size, thicker left ventricular walls, and higher serum ferritin and high‐sensitivity C‐reactive protein levels than the patients without DM. The aforementioned features may be possible risk factors for the development of adverse cardiac events in patients on hemodialysis.

[1]  J. Małyszko,et al.  Impact of Diabetes Mellitus on Survival in Patients with End-Stage Renal Disease: A Three-Year Follow-Up , 2011, Kidney and Blood Pressure Research.

[2]  O. Ozdogan,et al.  Left atrial volume predicts mortality in low-risk dialysis population on long-term low-salt diet. , 2010, American heart journal.

[3]  H. Nonoguchi,et al.  Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study , 2010, Clinical and Experimental Nephrology.

[4]  F. Locatelli,et al.  How Can Prognosis for Diabetic ESRD Be Improved? , 2010, Seminars in dialysis.

[5]  F. Torti,et al.  Ferritin for the clinician. , 2009, Blood reviews.

[6]  Chang-Chyi Jenq,et al.  Serum Ferritin Levels Predict All-Cause and Infection-Cause 1-Year Mortality in Diabetic Patients on Maintenance Hemodialysis , 2009, The American journal of the medical sciences.

[7]  K. Kalantar-Zadeh,et al.  Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[8]  B. Sobkowicz,et al.  Application of Myocardial Contrast Echocardiography for the Perfusion Assessment in Patients with End-Stage Renal Failure – Comparison with Coronary Angiography , 2008, American Journal of Nephrology.

[9]  C. Wanner,et al.  The challenge of sudden death in dialysis patients. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[10]  P. Nogueira,et al.  Serum ferritin and obstructive coronary artery disease: angiographic correlation. , 2007, Arquivos brasileiros de cardiologia.

[11]  B. Broumand Diabetes: Changing the Fate of Diabetics in the Dialysis Unit , 2006, Blood Purification.

[12]  D. Coyne Iron indices: what do they really mean? , 2006, Kidney international. Supplement.

[13]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[14]  P. Collinson,et al.  Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  A. Desideri,et al.  Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates. , 2005, International journal of cardiology.

[16]  S. You,et al.  Ferritin in atherosclerosis. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[17]  M. Rocco,et al.  Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. , 2004, Diabetes care.

[18]  C. Herzog Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. , 2003, Kidney international. Supplement.

[19]  S. Czekalski,et al.  [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis]. , 2002, Polskie Archiwum Medycyny Wewnetrznej.

[20]  I. Cavill Iron and erythropoietin in renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  S. Ganesh,et al.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. , 2001, Journal of the American Society of Nephrology : JASN.

[22]  R. Senior,et al.  A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction , 2001, Heart.

[23]  P. Saavedra-Santana,et al.  Diagnosis of iron deficiency in chronic renal failure. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  A. Hofman,et al.  Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. , 1999, The American journal of clinical nutrition.

[26]  H. Parving,et al.  Population based study of rates of multiple pregnancies in denmark, 1980-94 , 1997, BMJ.

[27]  Heikki Korpela,et al.  High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.

[28]  A. Wing,et al.  Hypertension and Cardiovascular Risk Factors in Hemodialyzed Diabetic Patients , 1985, Hypertension.

[29]  Usrds NIH, U. . Renal Data System: Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. , 2012 .

[30]  V. Jorgetti,et al.  Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[31]  D. Ansell Value of the real-time myocardial contrast echocardiography for risk stratification and for the detection of significant coronary stenosis in patients with end-stage renal disease , 2007 .

[32]  K. Kalantar-Zadeh,et al.  Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  S. Nashef,et al.  Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .